David Ferrera, CEO of RC Medical, is calling for greater attention to what he describes as the translational discipline in medical device innovation. With nearly three decades in the industry, Ferrera argues that many promising devices fail not because of weak science, but because developers lose sight of the end users—physicians and patients. He stresses that workflow is an integral part of the product, and ignoring it can lead to frustration and inefficiency in clinical settings.
Ferrera points to stroke as a critical area where practical innovation is needed. According to the U.S. Centers for Disease Control and Prevention (CDC), approximately 795,000 people experience a stroke each year in the United States, with someone suffering a stroke every 40 seconds. During an untreated ischemic stroke, researchers estimate that roughly 1.9 million brain cells die per minute, underscoring the urgency of efficient treatment. Ferrera believes these statistics reinforce the need for devices that fit seamlessly into existing clinical workflows rather than adding unnecessary steps.
"I've learned that physicians don't need more features," Ferrera said. "They need tools that fit naturally into the way they already work. Every unnecessary step can have consequences." His career includes leadership roles at companies such as Micrus Endovascular, MindFrame, and Blockade Medical, as well as positions at Microvention and Balt Global. Through RC Medical's venture studio model, he partners directly with physician-entrepreneurs to identify recurring clinical problems before product development begins. The guiding question is, "What keeps happening that shouldn't?"
Ferrera encourages engineers to spend more time observing procedures rather than assuming what physicians need. He recalls a doctor telling him, "The device works, but I spend more time preparing it than using it," which led to a simplified design instead of adding more technology. He also emphasizes that collaboration across engineering, medicine, manufacturing, and regulatory planning is essential from the start. "You cannot treat regulation, manufacturing, or workflow as problems to solve later," he said. "They shape the product from the beginning."
Industry data supports the challenge: a significant percentage of venture-backed startups fail to achieve sustainable commercial success, and medical device companies face additional hurdles in demonstrating safety, clinical effectiveness, manufacturing consistency, and physician adoption. Ferrera hopes more innovators will adopt a disciplined approach that prioritizes patient care over novelty. "The products that make the biggest difference are often the simplest," he said. "They remove friction. They save time. They help physicians focus on patients instead of equipment."
Ferrera also encourages individuals interested in healthcare innovation to take practical steps, such as learning how stroke symptoms are recognized using the FAST method, reading about how medical devices move from concept to clinical use, and listening to physicians describe challenges they face during procedures. He advocates for supporting organizations that fund stroke research and patient education, and for encouraging students interested in engineering to explore healthcare applications.
"People often think innovation starts with a breakthrough," Ferrera said. "Many times it starts by paying attention to one problem that everyone else has learned to work around." He hopes this mindset will inspire the next generation to build solutions that improve care while making healthcare teams more effective.
